Gliosarcoma

Common Name(s)

Gliosarcoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Gliosarcoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Gliosarcoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Gliosarcoma" returned 50 free, full-text research articles on human participants. First 3 results:

Gliosarcoma with smooth muscle cell differentiation: a case report.
 

Author(s): Mohamed Amine Bani, Alia Zehani, Ines Chelly, Aida Khadhar, Haifa Azouz, Hafedh Jemel, Slim Haouet, Nidhameddine Kchir

Journal: Tunis Med. 2016 Apr;94(4):337-338.

 

Last Updated: 5 Oct 2016

Go To URL
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
 

Author(s): Daxa M Patel, Paul M Foreman, L Burt Nabors, Kristen O Riley, G Yancey Gillespie, James M Markert

Journal: Hum Gene Ther Clin Dev. 2016 Jun;27(2):69-78.

 

M032 is a second-generation oncolytic herpes simplex virus (oHSV) that selectively replicates in tumor cells. M032 kills tumor cells directly through oncolytic replication and then proceeds to infect tumor cells in proximity, continuing the process of tumor destruction. In addition ...

Last Updated: 18 Jun 2016

Go To URL
Clinical outcome of patients with primary gliosarcoma treated with concomitant and adjuvant temozolomide: A single institutional analysis of 27 cases.
 

Author(s): G K Rath, D N Sharma, S Mallick, A K Gandhi, N P Joshi, K P Haresh, S Gupta, P K Julka

Journal: Indian J Cancer. ;52(4):599-603.

 

The prognosis of primary gliosarcoma (PGS) remains dismal with current treatment modalities. We analyzed the outcome of PGS patients treated with concurrent and adjuvant temozolomide (TMZ).

Last Updated: 10 Mar 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Gliosarcoma" returned 6 free, full-text review articles on human participants. First 3 results:

Primary gliosarcoma with long-survival: report of two cases and review of literature.
 

Author(s): Zhen Huo, Di Yang, Jie Shen, Yuan Li, Huanwen Wu, Yunxiao Meng, Shuying Zhang, Yufeng Luo, Jinling Cao, Zhiyong Liang

Journal:

 

Gliosarcoma (GS) is a rare high-grade malignant tumor with poor prognosis. The survival period of GS ranges from 4 to 18.5 months. Rarely would it be over 40 months. Survival of intraventricular GS is less than 8 months.

Last Updated: 22 Oct 2014

Go To URL
Gliosarcoma of the cerebellar hemisphere: a case report and review of the literature.
 

Author(s): Sung Kyoung Moon, Eui Jong Kim, Woo Suk Choi, Chang Woo Ryu, Bong Jin Park, Juhie Lee

Journal: Korean J Radiol. ;11(5):566-70.

 

Gliosarcoma is a rare central nervous system tumor usually located in the supratentorial area. Here we report a rare case of a gliosarcoma that developed in the cerebellar hemisphere in a 70-year-old woman. Computed tomography (CT) and magnetic resonance imaging (MRI) of the brain ...

Last Updated: 2 Sep 2010

Go To URL
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.
 

Author(s): Seunggu J Han, Isaac Yang, Tarik Tihan, Michael D Prados, Andrew T Parsa

Journal: J. Neurooncol.. 2010 Feb;96(3):313-20.

 

This report presents the historical experience, clinical presentation, treatment, prognosis, and pathogenesis of gliosarcoma described to date in the English literature. PubMed query of term "gliosarcoma" was performed, followed by a rigorous review of cited literature. Articles selected ...

Last Updated: 20 Jan 2010

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
 

Status: Recruiting

Condition Summary: Gliosarcoma; Recurrent Glioblastoma

 

Last Updated: 16 May 2017

Go to URL
BPM31510 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Previously Treated With Bevacizumab
 

Status: Recruiting

Condition Summary: Gliosarcoma; Recurrent Glioblastoma

 

Last Updated: 11 Jan 2017

Go to URL
Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
 

Status: Recruiting

Condition Summary: Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)

 

Last Updated: 28 Jul 2017

Go to URL